Keytruda killer: Chipscreen bags Chinese rights to Biocytogen's bispecific antibody

Keytruda killer: Chipscreen bags Chinese rights to Biocytogen's bispecific antibody

Submitted by admin on February 28, 2023 - 9:56am
Source: 
Fierce Biotech
News Tags: 
cancer
Biocytogen
Chipscreen NewWay Biosciences
Merck
Keytruda
YH008
Headline: 
Keytruda killer: Chipscreen bags Chinese rights to Biocytogen's bispecific antibody
snippet: 

Biocytogen Pharmaceuticals has found a partner for its push to develop a better checkpoint inhibitor, with Chipscreen NewWay Biosciences picking up regional rights to its PD-1xCD40 bispecific antibody.

Do Not Allow Advertisers to Use My Personal information